Wells Fargo Downgrades MEI Pharma (MEIP) to Market Perform
Tweet
Share
E-mailGet Alerts MEIP Hot Sheet
Price: $3.10 -4.91%
Rating Summary:
7 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 1
Rating Summary:
7 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 1
Join SI Premium – FREE
Wells Fargo downgraded MEI Pharma (NASDAQ: MEIP) from Outperform to Market Perform with a price target of $2-$2.25 (from $10-$11).
For an analyst ratings summary and ratings history on MEI Pharma click here. For more ratings news on MEI Pharma click here.
Shares of MEI Pharma closed at $1.93 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canaccord Genuity Downgrades Antofagasta Plc. (ANTO:LN) (ANFGF) to Hold
- Stifel Downgrades Knight Transportation (KNX) to Hold
- Raymond James Upgrades Kratos Defense & Security (KTOS) to Strong Buy
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
